Meadow Creek Investment Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$38M Sell
130,384
-864
-0.7% -$247K 0.75% 25
2019
Q2
$38.5M Sell
131,248
-4,016
-3% -$1.11M 0.77% 23
2019
Q1
$37M Buy
135,264
+5,456
+4% +$1.36M 0.75% 26
2018
Q4
$29.1M Buy
129,808
+384
+0.3% +$90.1K 0.67% 30
2018
Q3
$31.6M Sell
129,424
-7,792
-6% -$1.79M 0.62% 31
2018
Q2
$28.4M Sell
137,216
-3,872
-3% -$822K 0.6% 31
2018
Q1
$29.1M Sell
141,088
-288
-0.2% -$60.5K 0.63% 32
2017
Q4
$26.8M Buy
141,376
+2,560
+2% +$490K 0.58% 34
2017
Q3
$26.3M Sell
138,816
-15,056
-10% -$2.73M 0.61% 35
2017
Q2
$26.8M Sell
153,872
-5,376
-3% -$903K 0.64% 34
2017
Q1
$24.5M Sell
159,248
-6,352
-4% -$971K 0.59% 38
2016
Q4
$23.4M Buy
+165,600
New +$24.4M 0.6% 40

Other funds holding TMO

Meadow Creek Investment Management's TMO Position: Q3 2019 in Review

Meadow Creek Investment Management reduced its Thermo Fisher Scientific (TMO) stake by 0.66% in Q3 2019, selling an estimated $247K and leaving 130,384 shares worth $38M. The position accounts for 0.75% of the portfolio, ranked #25.

Meadow Creek Investment Management first reported a position in TMO in Q4 2016 and has held it in 12 quarters since. The position peaked at $38.5M in Q2 2019. 1,544 funds tracked by Wall St. Rank hold TMO as of Q3 2019.

  • Meadow Creek Investment Management held 130,384 shares of Thermo Fisher Scientific worth $38M as of Q3 2019.
  • Meadow Creek Investment Management sold 864 Thermo Fisher Scientific shares in Q3 2019, an estimated $247K.
  • Thermo Fisher Scientific made up 0.75% of Meadow Creek Investment Management's portfolio in Q3 2019, its #25 holding.
  • Meadow Creek Investment Management first reported a position in Thermo Fisher Scientific in Q4 2016 and has held it in 12 quarters since.
  • Meadow Creek Investment Management's Thermo Fisher Scientific position peaked at $38.5M in Q2 2019.
  • 1,544 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2019.

Based on Meadow Creek Investment Management's 13F filing for Q3 2019, filed 14 Nov 2019.